20061-24-9 Usage
Uses
Used in Organic Synthesis:
1,1-Cyclobutanedimethanol, 3-(phenylmethoxy)is used as a building block for the synthesis of various polymers and resins, contributing to the development of new materials with unique properties.
Used in Pharmaceutical Research:
Due to its unique structural properties, 1,1-Cyclobutanedimethanol, 3-(phenylmethoxy)has potential applications in the development of pharmaceuticals, where it may be utilized in the synthesis of novel drug candidates.
Used in Agrochemical Development:
1,1-Cyclobutanedimethanol, 3-(phenylmethoxy)may also be employed in the creation of new agrochemicals, potentially enhancing the effectiveness of pesticides or other agricultural products.
Used as a Reagent in Chemical Reactions:
In the field of chemistry, 1,1-Cyclobutanedimethanol, 3-(phenylmethoxy)can be used as a reagent to facilitate specific chemical reactions, contributing to the advancement of chemical processes.
Used as a Solvent in Certain Processes:
Additionally, 1,1-Cyclobutanedimethanol, 3-(phenylmethoxy)may serve as a solvent in certain chemical processes, providing a medium for reactions to occur and potentially improving the efficiency of these processes.
Overall, 1,1-Cyclobutanedimethanol, 3-(phenylmethoxy)has diverse potential uses across the fields of chemistry, materials science, and pharmaceutical research, making it a valuable compound for further exploration and application.
Check Digit Verification of cas no
The CAS Registry Mumber 20061-24-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,0,6 and 1 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 20061-24:
(7*2)+(6*0)+(5*0)+(4*6)+(3*1)+(2*2)+(1*4)=49
49 % 10 = 9
So 20061-24-9 is a valid CAS Registry Number.
20061-24-9Relevant academic research and scientific papers
Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B protein
Tai, Vincent W.-F.,Garrido, Dulce,Price, Daniel J.,Maynard, Andrew,Pouliot, Jeffrey J.,Xiong, Zhiping,Seal, John W.,Creech, Katrina L.,Kryn, Luz H.,Baughman, Todd M.,Peat, Andrew J.
, p. 2288 - 2294 (2014/05/20)
Two novel series of spirocyclic piperidine analogs appended to a pyrazolo[1,5-a]pyridine core were designed, synthesized and evaluated for their anti-HCV activity. A series of piperidine ketals afforded dispiro 6p which showed excellent in vitro anti-HCV activities (EC50 of 1.5 nM and 1.2 nM against genotype 1a and 1b replicons, respectively). A series of piperidine oxazolidinones afforded 27c which showed EC50's of 10.9 nM and 6.1 nM against 1a and 1b replicons, respectively. Both compounds 6p and 27c bound directly to non-structural NS4B protein in vitro (IC50's = 10.2 and 30.4 nM, respectively) and exhibited reduced potency in replicons containing resistance mutations encoding changes in the NS4B protein.
A method for synthesis of bicyclo[3.3.0]oct-1-en-3-ones from cyclobutanones with one-carbon ring expansion and its application to a formal synthesis of racemic 1-desoxyhypnophilin
Kashima, Hiroaki,Kawashima, Tadashi,Wakasugi, Daisuke,Satoh, Tsuyoshi
, p. 3953 - 3963 (2007/10/03)
A method for synthesis of 2-cyanobicyclo[3.3.0]oct-1-en-3-ones and 2-substituted bicyclo[3.3.0]oct-1-en-3-ones was developed by assembly of three components, cyclobutanones, chloromethyl p-tolyl sulfoxide, and nitriles, with one-carbon ring expansion of t
